Presented at PepTalk The Protein Science and Production Week: Overcoming ncAA Production Bottlenecks: High-titer Antibody Expression with 100% pAzF Incorporation at Scale and Minimal Host Toxicity

Presented at PepTalk The Protein Science and Production Week: Overcoming ncAA Production Bottlenecks: High-titer Antibody Expression with 100% pAzF Incorporation at Scale and Minimal Host Toxicity

ABSTRACT: A platform-based approach leveraging the Pfenex Expression Technology® was developed for implementing screening through lead optimization of novel ADCs As an example of the workflow, an Anti-GPCR VHH therapeutic candidate modified to include a single ncAA...
PepTalk: The Protein Science and Production Week 2026

PepTalk: The Protein Science and Production Week 2026

Primrose Bio presents and exhibits at PepTalk: The Protein Science and Production Week 2026 in San Diego, CA (January 19–22, 2026). Powered by Pseudomonas fluorescens, Pfenex Expression Technology® is a scalable microbial expression platform designed for high-yield...
Presented at Antibody Engineering & Therapeutics US 2025: Overcoming ncAA Production Bottlenecks: High-titer Antibody Expression with 100% pAzF Incorporation at Scale and Minimal Host Toxicity

Presented at Antibody Engineering & Therapeutics US 2025: Overcoming ncAA Production Bottlenecks: High-titer Antibody Expression with 100% pAzF Incorporation at Scale and Minimal Host Toxicity

ABSTRACT: A platform-based approach leveraging the Pfenex Expression Technology® was developed for implementing screening through lead optimization of novel ADCs. As an example of the workflow, an Anti-GPCR VHH therapeutic candidate modified to include a single ncAA...
Antibody Engineering  & Therapeutics US 2025

Antibody Engineering & Therapeutics US 2025

Primrose Bio presents and exhibits at Antibody Engineering & Therapeutics in San Diego, December 14-17, 2025.• Diane Retallack, PhD presents a talk on Primrose Bio’s rapid, robust solution for accelerating antibody screening P. fluorescens-based Pfenex...